FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bausch & Lomb's Free Cash Flow for the
three
months ended in Dec. 2024 was $-70 Mil. Bausch & Lomb's Revenue for the
three
months ended in Dec. 2024 was $1,280 Mil. Therefore, Bausch & Lomb's FCF Margin % for the quarter that ended in Dec. 2024 was -5.47%.
The historical rank and industry rank for Bausch & Lomb's FCF Margin % or its related term are showing as below:
BLCO'
s FCF Margin % Range Over the Past 10 Years
Min: -4.78 Med: 7.71 Max: 18.06
Current: -1.23
During the past 7 years, the highest FCF Margin % of Bausch & Lomb was 18.06%. The lowest was -4.78%. And the median was 7.71%.
BLCO's FCF Margin % is ranked better than 54.23% of 828
companies
in the Medical Devices & Instruments industry
Industry Median: -3.605
vs BLCO: -1.23
Bausch & Lomb FCF Margin % Historical Data
The historical data trend for Bausch & Lomb's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bausch & Lomb's FCF Margin %
For the Medical Instruments & Supplies subindustry, Bausch & Lomb's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bausch & Lomb's FCF Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bausch & Lomb's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Bausch & Lomb's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bausch & Lomb FCF Margin % Related Terms
Thank you for viewing the detailed overview of Bausch & Lomb's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BLCO has been successfully added to your 